173 related articles for article (PubMed ID: 9513075)
1. Expression of beta 1 integrins (very late antigens-4 and -5) on myeloma cells and clinical correlates in patients with multiple myeloma.
Nishinarita S; Shimada H; Ito T; Namiki H; Kawahira H; Sawada U; Horie T
J Int Med Res; 1998; 26(1):37-42. PubMed ID: 9513075
[TBL] [Abstract][Full Text] [Related]
2. Very late antigen (VLA) expression by normal and neoplastic human plasma cells; including an assessment of antibodies submitted to the Vth International Workshop on Leucocyte Differentiation Antigens using human myeloma cell lines.
Drew M; Barker HF; Ball J; Pearson C; Cook G; Franklin I
Leuk Res; 1996 Jul; 20(7):619-24. PubMed ID: 8795696
[TBL] [Abstract][Full Text] [Related]
3. [Myeloma precursor cells].
Iwato K; Kawano MM
Rinsho Ketsueki; 1993 Apr; 34(4):433-8. PubMed ID: 7685432
[TBL] [Abstract][Full Text] [Related]
4. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
[TBL] [Abstract][Full Text] [Related]
5. Expression of adhesion molecules on myeloma cells.
Tatsumi T; Shimazaki C; Goto H; Araki S; Sudo Y; Yamagata N; Ashihara E; Inaba T; Fujita N; Nakagawa M
Jpn J Cancer Res; 1996 Aug; 87(8):837-42. PubMed ID: 8797890
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin promotes adhesion of primitive human hemopoietic cells to fibronectin and vascular cell adhesion molecule-1: role of activation of very late antigen (VLA)-4 and VLA-5.
Cui L; Ramsfjell V; Borge OJ; Veiby OP; Lok S; Jacobsen SE
J Immunol; 1997 Aug; 159(4):1961-9. PubMed ID: 9257862
[TBL] [Abstract][Full Text] [Related]
7. Differential use of very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells to adhere to transforming growth factor-beta1-treated bone marrow stroma.
Robledo MM; Sanz-Rodriguez F; Hidalgo A; Teixidó J
J Biol Chem; 1998 May; 273(20):12056-60. PubMed ID: 9575147
[TBL] [Abstract][Full Text] [Related]
8. A new phenotypic classification of bone marrow plasmacytosis.
Kawano MM; Mihara K; Tsujimoto T; Huang N; Kuramoto A
Int J Hematol; 1995 Jun; 61(4):179-88. PubMed ID: 8547606
[TBL] [Abstract][Full Text] [Related]
9. [Detection of myeloma cells in the peripheral blood using flow cytometry].
Adam Z; Klabusay M; Vorlícek J; Hájek R
Vnitr Lek; 1997 Sep; 43(9):592-8. PubMed ID: 9750468
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery.
Möhle R; Murea S; Kirsch M; Haas R
Exp Hematol; 1995 Dec; 23(14):1535-42. PubMed ID: 8542944
[TBL] [Abstract][Full Text] [Related]
11. Integrin VLA-5 negative primary plasma cell leukemia.
Ohtake K; Takeuchi T; Saito K; Ito T; Ito I; Aoki K; Takano Y; Amano K; Hosono O; Koide J
Intern Med; 1993 Jul; 32(7):565-8. PubMed ID: 8286836
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
13. VLA-4-dependent myeloma cell adhesion.
Sanz-Rodríguez F; Teixidó J
Leuk Lymphoma; 2001 Apr; 41(3-4):239-45. PubMed ID: 11378537
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative expression of the adhesion receptors VLA-4, VLA-5, L-selectin, MAC-1, and ICAM-1 on the surface of CD34+ cells].
Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
Transfus Clin Biol; 2001 Dec; 8(6):453-9. PubMed ID: 11802606
[TBL] [Abstract][Full Text] [Related]
15. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease].
Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A
Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405
[TBL] [Abstract][Full Text] [Related]
16. Differential utilization of VLA-4 (alpha 4 beta 1) and -5 (alpha 5 beta 1) integrins during the development of mouse bone marrow-derived mast cells.
Fehlner-Gardiner CC; Uniyal S; von Ballestrem CG; Chan BM
Differentiation; 1996 Sep; 60(5):317-25. PubMed ID: 8855375
[TBL] [Abstract][Full Text] [Related]
17. Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics.
Vila L; Thomas X; Campos L; Sabido O; Archimbaud E
Exp Hematol; 1995 Jun; 23(6):514-8. PubMed ID: 7768307
[TBL] [Abstract][Full Text] [Related]
18. Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma.
Teixidó J; Hemler ME; Greenberger JS; Anklesaria P
J Clin Invest; 1992 Aug; 90(2):358-67. PubMed ID: 1379610
[TBL] [Abstract][Full Text] [Related]
19. Different expression of adhesion molecules on myeloid and B-lymphoid CD34+ progenitors in normal bone marrow.
De Waele M; Renmans W; Damiaens S; Flament J; Schots R; Van Riet I
Eur J Haematol; 1997 Nov; 59(5):277-86. PubMed ID: 9414638
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of stem cells from umbilical cord blood: expression of cell adhesion molecules.
Dravid G; Rao SG
Stem Cells; 2002; 20(2):183-9. PubMed ID: 11897875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
